Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Methionine as a regulator of bone remodeling with fasting
Tânia Amorim, Naveen G.V. Kumar, Natalie L. David, William Dion, Trishya Pagadala, Nandini K. Doshi, Bokai Zhu, Andrey Parkhitko, Matthew L. Steinhauser, Pouneh K. Fazeli
Tânia Amorim, Naveen G.V. Kumar, Natalie L. David, William Dion, Trishya Pagadala, Nandini K. Doshi, Bokai Zhu, Andrey Parkhitko, Matthew L. Steinhauser, Pouneh K. Fazeli
View: Text | PDF
Research Article Endocrinology Metabolism

Methionine as a regulator of bone remodeling with fasting

  • Text
  • PDF
Abstract

Caloric restriction improves metabolic health but is often complicated by bone loss. We studied bone parameters in humans during a 10-day fast and identified candidate metabolic regulators of bone turnover. Pro-collagen 1 intact N-terminal pro-peptide (P1NP), a bone formation marker, decreased within 3 days of fasting. Whereas dual-energy x-ray absorptiometry measures of bone mineral density were unchanged after 10 days of fasting, high-resolution peripheral quantitative CT demonstrated remodeling of bone microarchitecture. Pathway analysis of longitudinal metabolomics data identified one-carbon metabolism as fasting dependent. In cultured osteoblasts, we tested the functional significance of one-carbon metabolites modulated by fasting, finding that methionine — which surged after 3 days of fasting — affected markers of osteoblast cell state in a concentration-dependent manner, in some instances exhibiting a U-shaped response with both low and high concentrations driving putative antibone responses. Administration of methionine to mice for 5 days recapitulated some fasting effects on bone, including a reduction in serum P1NP. In conclusion, a 10-day fast in humans led to remodeling of bone microarchitecture, potentially mediated by a surge in circulating methionine. These data support an emerging model that points to a window of optimal methionine exposure for bone health.

Authors

Tânia Amorim, Naveen G.V. Kumar, Natalie L. David, William Dion, Trishya Pagadala, Nandini K. Doshi, Bokai Zhu, Andrey Parkhitko, Matthew L. Steinhauser, Pouneh K. Fazeli

×

Figure 3

Cultured osteoblasts are sensitive to methionine concentration.

Options: View larger image (or click on image) Download as PowerPoint
Cultured osteoblasts are sensitive to methionine concentration.
(A) Expe...
(A) Experimental design. (B) Gene expression measured by qPCR of osteoblasts treated with no supplemental methionine or methionine excess (100 μM and 500 μM) for 48 hours. The mRNA expression of each gene was normalized to GAPDH. Data shown are relative to control (i.e., methionine 20 μM); **P < 0.01, 1-way ANOVA/Dunnett’s test for multiple comparisons (n = 5 biological replicates). (C) Gene expression measured by qPCR of osteoblasts treated with 2 high doses of betaine (50 μM and 250 μM), homocysteine (15 μM and 75 μM), or dimethylglycine (5 μM and 25 μM) for 48 hours. The mRNA expression of each gene was normalized to GAPDH. Data shown are relative to control (i.e., no treatment); n = 4 biological replicates. (D) Western blot analyses of osteoblasts exposed to similar ranges of methionine concentrations as in B and C, focused on 2 core transcription factors, RUNX2 and ATF4. (E) Western blot analyses of osteoblasts exposed to a similar range of methionine concentrations as in B, focused on chromatin methyl marks. (F) Bone formation markers measured by ELISA in the media of cultured osteoblasts exposed to variable methionine concentrations. *P < 0.05, 1-way ANOVA/Dunnett’s test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts